Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006 Aug; 74(2):90-9.

View in: PubMed

subject areas

Adult
Body Weight
Bone and Bones
Bone Density
Cohort Studies
Contraceptive Agents, Female
Female
Humans
Lipids
Medroxyprogesterone Acetate
Osteocalcin
Prospective Studies

authors with profiles

Valerie Montgomery Rice

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support